Panacea Biotec Limited — Others, 26-03-2025: Trading Window

Panacea Biotec Limited has announced a board meeting to approve the audited financial results for the quarter and half-year ending March 31, 2025. The company will implement a closure of its trading window for all Designated Persons and Insiders from April 1, 2025, until 48 hours after the announcement of these results.

This measure is typically aimed at maintaining compliance with insider trading regulations, reflecting the company's commitment to governance practices. Investors might view this as a sign of transparency; however, the closure of the trading window could temporarily limit trading activities, presenting a potential risk for short-term liquidity.